{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T06:59:56Z","timestamp":1764831596800,"version":"3.46.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s42000-025-00675-x","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T02:03:29Z","timestamp":1748397809000},"page":"1193-1198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hypertensive retinopathy as the first manifestation of extra-adrenal paraganglioma"],"prefix":"10.1007","volume":"24","author":[{"given":"Z","family":"Karagiannidou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Bontzos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Plaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Makrygiannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"issue":"5","key":"675_CR1","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/s0030-6665(05)70351-0","volume":"34","author":"PG Wasserman","year":"2001","unstructured":"Wasserman PG, Savargaonkar P (2001) Paragangliomas: classification, pathology, and differential diagnosis. Otolaryngol Clin North Am 34(5):845\u2013862. https:\/\/doi.org\/10.1016\/s0030-6665(05)70351-0","journal-title":"Otolaryngol Clin North Am"},{"issue":"1","key":"675_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","volume":"33","author":"O Mete","year":"2022","unstructured":"Mete O, Asa SL, Gill AJ, Kimura N, de Krijger RR, Tischler AS (2022) Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas. Endocr Pathol 33(1):90\u2013114. https:\/\/doi.org\/10.1007\/s12022-022-09704-6","journal-title":"Endocr Pathol"},{"issue":"2","key":"675_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/bf00405502","volume":"96","author":"T Amemiya","year":"1980","unstructured":"Amemiya T, Kadoya M (1980) Paraganglioma in the orbit. J Cancer Res Clin Oncol 96(2):169\u2013179. https:\/\/doi.org\/10.1007\/bf00405502","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"675_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/wno.0000000000000281","volume":"35","author":"P Lertakyamanee","year":"2015","unstructured":"Lertakyamanee P, Srinivasan A, De Lott LB, Trobe JD (2015) Papilledema and vision loss caused by jugular paragangliomas. J Neuroophthalmol 35(4):364\u2013370. https:\/\/doi.org\/10.1097\/wno.0000000000000281","journal-title":"J Neuroophthalmol"},{"issue":"9","key":"675_CR5","doi-asserted-by":"publisher","first-page":"392","DOI":"10.5694\/mja2.51929","volume":"218","author":"N Singh","year":"2023","unstructured":"Singh N, Chaudhri K, Catt C (2023) Hypertensive retinopathy in the paediatric setting. Med J Aust 218(9):392\u2013393. https:\/\/doi.org\/10.5694\/mja2.51929","journal-title":"Med J Aust"},{"issue":"5","key":"675_CR6","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1055\/s-2008-1027355","volume":"225","author":"D Petkou","year":"2008","unstructured":"Petkou D, Petropoulos IK, Kordelou A, Katsimpris JM (2008) Severe bilateral hypertensive retinopathy and optic neuropathy in a patient with pheochromocytoma. Klin Monatsbl Augenheilkd 225(5):500\u2013503. https:\/\/doi.org\/10.1055\/s-2008-1027355","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"2","key":"675_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4103\/2320-3897.183720","volume":"4","author":"V Vohra","year":"2016","unstructured":"Vohra V, Chawla H, Malik PK (2016) Bilateral exudative retinal detachment in a case of paraganglioma. J Clin Ophthalmol Res 4(2):92\u201395. https:\/\/doi.org\/10.4103\/2320-3897.183720","journal-title":"J Clin Ophthalmol Res"},{"key":"675_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s12020-013-0007-y","volume":"45","author":"A Mazza","year":"2014","unstructured":"Mazza A, Armigliato M, Marzola MC, Schiavon L, Montemurro D, Vescovo G et al (2014) Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features. Endocrine 45:469\u2013478. https:\/\/doi.org\/10.1007\/s12020-013-0007-y","journal-title":"Endocrine"},{"key":"675_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1196\/annals.1353.002","volume":"1073","author":"WF Young Jr","year":"2006","unstructured":"Young WF Jr (2006) Paragangliomas: clinical overview. Ann N Y Acad Sci 1073:21\u201329. https:\/\/doi.org\/10.1196\/annals.1353.002","journal-title":"Ann N Y Acad Sci"},{"key":"675_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-211184","author":"MM Alface","year":"2015","unstructured":"Alface MM, Moniz P, Jesus S, Fonseca C (2015) Pheochromocytoma: clinical review based on a rare case in adolescence. BMJ Case Rep bcr2015211184. https:\/\/doi.org\/10.1136\/bcr-2015-211184","journal-title":"BMJ Case Rep bcr2015211184"},{"issue":"12","key":"675_CR11","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1097\/01.hjh.0000251887.01885.54","volume":"24","author":"N Reisch","year":"2006","unstructured":"Reisch N, Peczkowska M, Januszewicz A, Neumann HP (2006) Pheochromocytoma: presentation, diagnosis and treatment. J Hypertens 24(12):2331\u20132339. https:\/\/doi.org\/10.1097\/01.hjh.0000251887.01885.54","journal-title":"J Hypertens"},{"issue":"10","key":"675_CR12","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1210\/jc.2003-030720","volume":"88","author":"YC Kudva","year":"2003","unstructured":"Kudva YC, Sawka AM, Young WF Jr (2003) The laboratory diagnosis of adrenal pheochromocytoma: the Mayo clinic experience. J Clin Endocrinol Metab 88(10):4533\u20134539. https:\/\/doi.org\/10.1210\/jc.2003-030720","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"675_CR13","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1373\/clinchem.2014.224832","volume":"60","author":"G Eisenhofer","year":"2014","unstructured":"Eisenhofer G, Peitzsch M (2014) Laboratory evaluation of pheochromocytoma and paraganglioma. Clin Chem 60(12):1486\u20131499. https:\/\/doi.org\/10.1373\/clinchem.2014.224832","journal-title":"Clin Chem"},{"issue":"6","key":"675_CR14","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JWM Lenders","year":"2014","unstructured":"Lenders JWM, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SKG, Murad MH et al (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(6):1915\u20131942. https:\/\/doi.org\/10.1210\/jc.2014-1498","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"675_CR15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1210\/jc.2002-021251","volume":"88","author":"AM Sawka","year":"2003","unstructured":"Sawka AM, Jaeschke R, Singh RJ, Young WF Jr (2003) A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 88(2):553\u2013558. https:\/\/doi.org\/10.1210\/jc.2002-021251","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"675_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3978\/j.issn.2227-684x.2014.11.06","volume":"4","author":"S McDermott","year":"2015","unstructured":"McDermott S, McCarthy CJ, Blake MA (2015) Images of pheochromocytoma in adrenal glands. Gland Surg 4(4):350\u2013358. https:\/\/doi.org\/10.3978\/j.issn.2227-684x.2014.11.06","journal-title":"Gland Surg"},{"issue":"1","key":"675_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10689-004-2155-y","volume":"4","author":"I Brink","year":"2005","unstructured":"Brink I, Hoegerle S, Klisch J, Bley TA (2005) Imaging of pheochromocytoma and paraganglioma. Fam Cancer 4(1):61\u201368. https:\/\/doi.org\/10.1007\/s10689-004-2155-y","journal-title":"Fam Cancer"},{"issue":"2","key":"675_CR18","doi-asserted-by":"publisher","first-page":"e231245","DOI":"10.1136\/bcr-2019-231245","volume":"13","author":"A Banerjee","year":"2020","unstructured":"Banerjee A, Nayak B, Verma G, Parija S (2020) Resolution of grade IV hypertensive retinopathy in an adult with pheochromocytoma: post-tumor resection. BMJ Case Rep CP 13(2):e231245. https:\/\/doi.org\/10.1136\/bcr-2019-231245","journal-title":"BMJ Case Rep CP"},{"issue":"4","key":"675_CR19","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.3892\/etm.2018.5871","volume":"15","author":"F \u010ctvrtl\u00edk","year":"2018","unstructured":"\u010ctvrtl\u00edk F, Koranda P, Schovanek J, Skarda J, Hartmann I, T\u00fcd\u00f6s Z (2018) Current diagnostic imaging of pheochromocytomas and implications for therapeutic strategy. Exp Ther Med 15(4):3151\u20133160. https:\/\/doi.org\/10.3892\/etm.2018.5871","journal-title":"Exp Ther Med"},{"issue":"18","key":"675_CR20","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.26355\/eurrev_202209_29742","volume":"26","author":"E Di Marco","year":"2022","unstructured":"Di Marco E, Aiello F, Lombardo M, Di Marino M, Missiroli F et al (2022) A literature review of hypertensive retinopathy: systemic correlations and new technologies. Eur Rev Med Pharmacol Sci 26(18):6424\u20136443. https:\/\/doi.org\/10.26355\/eurrev_202209_29742","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"675_CR21","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s00259-012-2215-8","volume":"39","author":"D Ta\u00efeb","year":"2012","unstructured":"Ta\u00efeb D, Timmers HJ, Hindi\u00e9 E, Guillet BA, Neumann HP, Walz MK et al (2012) EANM 2012 guidelines for radionuclide imaging of pheochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging 39(12):1977\u20131995. https:\/\/doi.org\/10.1007\/s00259-012-2215-8","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"675_CR22","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.2967\/jnumed.108.052373","volume":"49","author":"I Ilias","year":"2008","unstructured":"Ilias I, Chen CC, Carrasquillo JA, Whatley M, Ling A, Lazurova I et al (2008) Comparison of 6-[18F]-fluorodopamine PET with 123I-MIBG and 111In-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma. J Nucl Med 49(10):1613\u20131619. https:\/\/doi.org\/10.2967\/jnumed.108.052373","journal-title":"J Nucl Med"},{"issue":"1","key":"675_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2265.2008.03496.x","volume":"71","author":"HJ Timmers","year":"2009","unstructured":"Timmers HJ, Eisenhofer G, Carrasquillo JA, Chen CC, Whatley M, Ling A et al (2009) Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for diagnosis and localization of non-metastatic and metastatic pheochromocytoma. Clin Endocrinol (Oxf) 71(1):11\u201317. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03496.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"675_CR24","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1210\/jc.2009-1248","volume":"94","author":"HJLM Timmers","year":"2009","unstructured":"Timmers HJLM, Chen CC, Carrasquillo JA, Whatley M, Ling A, Havekes B et al (2009) Comparison of 18F-fluoro-L-DOPA, 18F-fluorodeoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 94(12):4757\u20134767. https:\/\/doi.org\/10.1210\/jc.2009-1248","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"675_CR25","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1210\/jc.2009-0902","volume":"94","author":"HB Fiebrich","year":"2009","unstructured":"Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR et al (2009) 6-[18F]-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with 123I-MIBG scintigraphy, CT, and MRI in localizing tumors causing catecholamine excess. J Clin Endocrinol Metab 94(10):3922\u20133930. https:\/\/doi.org\/10.1210\/jc.2009-0902","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-025-00675-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-025-00675-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-025-00675-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T05:32:32Z","timestamp":1764826352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-025-00675-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["675"],"URL":"https:\/\/doi.org\/10.1007\/s42000-025-00675-x","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"type":"print","value":"1109-3099"},{"type":"electronic","value":"2520-8721"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"19 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}